Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2025)

Anaptysbio (ANAB) has disclosed Other Working Capital Changes for 10 consecutive years, with -$494000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 73.77% year-over-year to -$494000.0, compared with a TTM value of -$1.9 million through Dec 2025, up 39.9%, and an annual FY2025 reading of -$1.9 million, up 39.9% over the prior year.
  • Other Working Capital Changes was -$494000.0 for Q4 2025 at Anaptysbio, down from -$487000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $5.4 million in Q4 2023 and bottomed at -$6.5 million in Q3 2022.
  • Average Other Working Capital Changes over 5 years is -$9650.0, with a median of -$399000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes crashed 1405.43% in 2021, then surged 9545.0% in 2022.
  • Year by year, Other Working Capital Changes stood at $20000.0 in 2021, then soared by 9545.0% to $1.9 million in 2022, then soared by 180.46% to $5.4 million in 2023, then crashed by 134.81% to -$1.9 million in 2024, then soared by 73.77% to -$494000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for ANAB at -$494000.0 in Q4 2025, -$487000.0 in Q3 2025, and -$482000.0 in Q2 2025.